Pharmafile Logo
Pharmafocus logo
Advanced Search

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026
Symbiosis Pharmaceutical Services

Symbiosis Pharmaceutical Services (Symbiosis), a global contract development and manufacturing organisation (CDMO) specialising in the GMP sterile fill-finish manufacturing of …

Appointment

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026
Research and Development Curie.Bio, Secarna Pharmaceuticals, partnership

Secarna Pharmaceuticals has announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio. The collaboration, first announced …

News

eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer

March 6, 2026
eXmoor Pharma

eXmoor Pharma has appointed Manuel Balbuena as Chief Commercial Officer (CCO). Manuel brings more than 15 years of commercial leadership …

Appointment

ESTEVE CDMO commences $15.5m expansion of US facility

March 6, 2026
Manufacturing and Production ESTEVE, US, expansion

ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, …

News

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026
Research and Development Siemens Healthineers

Siemens Healthineers has opened a new Centre of Excellence for Immunoassay Instrument Research & Development in Swords, Ireland. Over 10m …

News

Everdrone announces new board of directors to drive expansion

February 19, 2026
Everdrone

Everdrone, a provider of autonomous drone systems for use in healthcare and emergency response, has appointed a new board of …

Appointment

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026
Research and Development Eylea HD, Opthalmology, Regeneron

Regeneron has presented data for Eylea HD (aflibercept) 8mg injection for retinal disease. The data was presented as part of …

News

Indegene completes acquisition of Cake Health

February 18, 2026
Cake Health, Indegene

Indegene, a life sciences solutions company, has announced its acquisition of Cake Health, a healthcare agency, as well as its …

News

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026
Manufacturing and Production Gedeon Richter UK, Neurology

Gedeon Richter UK has announced its acquisition of full marketing and distribution rights to Reagila (cariprazine), a schizophrenia treatment, from …

News

ENA Respiratory doses first patients with INNA-051 antiviral nasal spray

February 17, 2026
Ear Nose & throat, Ena Respiratory

ENA Respiratory, a clinical-stage biopharmaceutical company specialising in the prevention of viral respiratory infections, has announced the first dosing of …

News

New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone

February 16, 2026
Research and Development Cardiology, Carvolix

Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic implants, has completed the acquisition …

News

Qlaris Bio appoints Robert Warner to board of directors

February 16, 2026
Qlaris Bio

Qlaris Bio has appointed Robert Warner to its board of directors. Warner brings significant experience in life sciences leadership to …

Appointment

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026
Research and Development Cardiology, Rhythm AI, atrial fibrillation

Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …

News

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026
Manufacturing and Production iOrganBio

iOrganBio has announced the appointment of Karol Jarzabek as Chief Operating Officer (COO). Jarzabek specialises in operational management and business …

Appointment

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026
Business Services, Consultancy Ensera Design

Ensera Design, a healthcare product innovation consultancy, has announced the expansion of its UK leadership team with multiple new appointments. …

Appointment

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026
Research and Development Infinitopes, Oncology

Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …

News

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026
Angelini Pharma

Angelini Pharma, the pharmaceutical branch of Angelini Industries, has announced the appointment of Roberto Scrivo as Chief of External Affairs, …

Appointment

Hongene Biotech receives Gates Foundation grant to drive mRNA vaccine production

February 10, 2026
Manufacturing and Production Hongene Biotech, mRNA vaccine

Hongene Biotech, a contract development and manufacturing organisation (CDMO) and ribonucleic acid (RNA) technology provider, has announced the receipt of …

News

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026
Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …

News

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026
AstronauTx, chair of the board

AstronauTx has announced the appointment of Adam Rosenberg as Chair of its Board of Directors. Rosenberg’s leadership experience includes holding …

Appointment

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026
Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …

News
The Gateway to Local Adoption Series

Latest content

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026

eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer

March 6, 2026

ESTEVE CDMO commences $15.5m expansion of US facility

March 6, 2026

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026